Charlottesville, VIRGINIA1 Active Studies

Cystic Fibrosis Clinical Trials in Charlottesville, VIRGINIA

Find 1 actively recruiting cystic fibrosis clinical trials in Charlottesville, VIRGINIA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
44
Enrolling

Recruiting Cystic Fibrosis Studies in Charlottesville

About Cystic Fibrosis Clinical Trials in Charlottesville

Cystic fibrosis is a genetic disorder that causes thick, sticky mucus to build up in the lungs, digestive tract, and other organs. It is caused by mutations in the CFTR gene. CFTR modulator therapies have dramatically improved outcomes, along with airway clearance techniques and nutritional support.

There are currently 1 cystic fibrosis clinical trials recruiting participants in Charlottesville, VIRGINIA. These studies are seeking a combined 44 participants. Research is being sponsored by Children's Hospital Medical Center, Cincinnati. Clinical trial participation is free and participants receive study-related medical care at no cost.

Cystic Fibrosis Clinical Trials in Charlottesville — FAQ

Are there cystic fibrosis clinical trials in Charlottesville?

Yes, there are 1 cystic fibrosis clinical trials currently recruiting in Charlottesville, VIRGINIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charlottesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charlottesville research site will contact you about next steps.

Are clinical trials in Charlottesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charlottesville studies also compensate for your time and travel.

What cystic fibrosis treatments are being tested?

The 1 active trials in Charlottesville are testing new therapies including novel drugs, biologics, and treatment approaches for cystic fibrosis.

Data updated March 2, 2026 from ClinicalTrials.gov